Article

Top 5 Cardiology Apps

 


Among the various heart disease apps that can help the busy cardiologist in their daily practice are reference apps for drugs, tests, treatments, devices, or reimbursements and education apps for the provider or patient. In the slides that follow are 5 of the best medical apps for specialists and trainees in cardiovascular disease based on their potential usefulness, simplicity/ease of use, and topical content.  

The apps are the author’s choice.

 

 

 

 

 

AnticoagEvaluator provides therapy selection options from the ACC/AHA/HRS Atrial Fibrillation Guidelines based on individual risk of stroke. It can be used to calculate a patient’s stroke risk, bleed risk, and renal function.

Logo image courtesy of American College of Cardiology

 

 

CathSource provides a searchable database with more than 30 videos of catheterization procedures as well as detailed overviews of important catheterization and angiography topics and reviews of medical literature.

Logo image courtesy of ECGSource LLC.

 

 

HeartEvidence Pro: Landmark Trials in Cardiology reviews the top trials in cardiology to help physicians and medical students easily find landmark trials. Providers who would like to contribute to the app may contact doctorjhmpark@gmail.com.

Logo image courtesy of JoongHeum Park, MD

 

HeartDecide is a point-of-care education tool that includes the ability to compare abnormal and normal images, 3D animation and videos of the most common CV conditions and procedures.

Logo image courtesy of Orca Health, Inc.

 

Prognosis: Cardiology contains multiple peer-reviewed cases based on real-life patients and covers a broad spectrum of cardiovascular disorders—from arrhythmias to valvular heart disease.

Logo image courtesy of Medical Joyworks

 

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.